Correlation Between Xenetic Biosciences and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Xenetic Biosciences and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xenetic Biosciences and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xenetic Biosciences and Unicycive Therapeutics, you can compare the effects of market volatilities on Xenetic Biosciences and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xenetic Biosciences with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xenetic Biosciences and Unicycive Therapeutics.
Diversification Opportunities for Xenetic Biosciences and Unicycive Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Xenetic and Unicycive is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Xenetic Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xenetic Biosciences are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Xenetic Biosciences i.e., Xenetic Biosciences and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Xenetic Biosciences and Unicycive Therapeutics
Given the investment horizon of 90 days Xenetic Biosciences is expected to generate 0.62 times more return on investment than Unicycive Therapeutics. However, Xenetic Biosciences is 1.62 times less risky than Unicycive Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 432.00 in Xenetic Biosciences on November 5, 2024 and sell it today you would lose (1.00) from holding Xenetic Biosciences or give up 0.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Xenetic Biosciences vs. Unicycive Therapeutics
Performance |
Timeline |
Xenetic Biosciences |
Unicycive Therapeutics |
Xenetic Biosciences and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Xenetic Biosciences and Unicycive Therapeutics
The main advantage of trading using opposite Xenetic Biosciences and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xenetic Biosciences position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Xenetic Biosciences vs. Transcode Therapeutics | Xenetic Biosciences vs. ZyVersa Therapeutics | Xenetic Biosciences vs. Immix Biopharma | Xenetic Biosciences vs. Phio Pharmaceuticals Corp |
Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |